Drawing for AURORA

USPTO serial 50138746

AURORA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ORSCHELN, COLLEEN J
Law office
TMO LAW OFFICE 132

What this means

Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months. Monitor TSDR for the examiner's first action. No filing is required until an office action or other requirement is issued.

Status 638: Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months.

Need help with AURORA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Makiko Coffland

Makiko Coffland Christensen O'Connor Johnson Kindness1201 Third Avenue, Suite 3600Seattle, WA 98101United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical additives for use in the manufacture of pharmaceuticals; Active chemical ingredients for use in the manufacture of pharmaceuticals; Biological preparations for use in industry and scienceACTIVE—
003Cosmetic preparations; Cosmetics sold as an integral component of non-medicated skincare preparationsACTIVE—
005Pharmaceutical preparations for the treatment and prevention of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, hematological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain; Pharmaceutical preparations for the treatment and prevention of glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Diagnostic substances for medical useACTIVE—
010Medical apparatus for use in treating cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, hematological diseases and disorders; Medical apparatus for use in treating gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain, glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical devices for use in treating or diagnosing cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, hematological diseases and disorders; Medical devices for use in treating or diagnosing gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain, glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skinACTIVE—
041Providing information about education; Arranging and conducting of seminars and workshops in the field of science, health, medicine, pharmacy and beauty; Publishing e-books in the field of science, health, medicine, pharmacy and beauty; Providing online non-downloadable journals in the field of science, health, medicine, pharmacy and beauty; Publishing and issuing scientific papers in relation to medical technology; Instruction in the field of cosmetologyACTIVE—
044Pharmaceutical advice; Pharmaceutical compounding services; Dispensing of pharmaceuticals; Medical services; Healthcare; Providing healthcare information; Providing educational information about healthcare; Internet-based health care information services; Providing medical information; Medical and pharmaceutical consultation; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing news and information in the field of medicineACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 20, 2026DOCKASSIGNED TO EXAMINER—
Oct 20, 2026DOCKASSIGNED TO EXAMINER—
Oct 20, 2026DOCKASSIGNED TO EXAMINER—
Sep 30, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 30, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 30, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance